HK1184187A1 - Lactic bacterium having an effect of ameliorating metabolic syndrome - Google Patents

Lactic bacterium having an effect of ameliorating metabolic syndrome

Info

Publication number
HK1184187A1
HK1184187A1 HK13111466.7A HK13111466A HK1184187A1 HK 1184187 A1 HK1184187 A1 HK 1184187A1 HK 13111466 A HK13111466 A HK 13111466A HK 1184187 A1 HK1184187 A1 HK 1184187A1
Authority
HK
Hong Kong
Prior art keywords
effect
metabolic syndrome
lactic bacterium
ameliorating metabolic
ameliorating
Prior art date
Application number
HK13111466.7A
Other languages
Chinese (zh)
Inventor
利光孝之
池上秀二
伊藤裕之
Original Assignee
株式會社明治
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式會社明治 filed Critical 株式會社明治
Publication of HK1184187A1 publication Critical patent/HK1184187A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK13111466.7A 2010-07-30 2013-10-10 Lactic bacterium having an effect of ameliorating metabolic syndrome HK1184187A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010172256 2010-07-30
PCT/JP2011/067239 WO2012014971A1 (en) 2010-07-30 2011-07-28 Lactic bacterium having an effect of ameliorating metabolic syndrome

Publications (1)

Publication Number Publication Date
HK1184187A1 true HK1184187A1 (en) 2014-01-17

Family

ID=45530171

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13111466.7A HK1184187A1 (en) 2010-07-30 2013-10-10 Lactic bacterium having an effect of ameliorating metabolic syndrome

Country Status (4)

Country Link
JP (1) JP5076029B2 (en)
CN (1) CN103314099B (en)
HK (1) HK1184187A1 (en)
WO (1) WO2012014971A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI589227B (en) * 2011-12-06 2017-07-01 雪印惠乳業股份有限公司 Diet that shows high survivability of lactobacillus gasseri and method for producing the same
JP5995593B2 (en) * 2012-08-02 2016-09-21 丸善製薬株式会社 Anti-inflammatory agent
JP2014172902A (en) * 2013-03-05 2014-09-22 Shonan Institute For Medical & Preventive Science Diabetic conditions improving agent of sargassum horneri fermentation product using lactobacillus plantarum
JP6788966B2 (en) * 2015-12-24 2020-11-25 丸善製薬株式会社 Cosmetics
CN107028985A (en) * 2016-02-04 2017-08-11 深圳华大基因研究院 Application of the heavy wall mushroom probiotics in preventing and/or treating diabetes and its relevant disease
JP7057059B2 (en) * 2016-08-22 2022-04-19 株式会社明治 Method for producing a culture of Lactobacillus plantarum
KR102250597B1 (en) * 2017-11-20 2021-05-11 경희대학교 산학협력단 Novel lactic acid bacteria and use thereof
JP7013419B2 (en) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 Bifidobacterium with low inflammatory cytokine production-inducing activity but high anti-inflammatory cytokine production-inducing activity
JP7364390B2 (en) * 2019-08-19 2023-10-18 株式会社明治 Composition for improving sugar metabolism
EP4104844A4 (en) 2019-12-13 2024-02-14 Meiji Co., Ltd Composition for lowering heart rate
JPWO2021261423A1 (en) 2020-06-22 2021-12-30
JP7082827B2 (en) * 2020-09-09 2022-06-09 丸善製薬株式会社 Cosmetics
CN112190600B (en) * 2020-09-11 2022-04-26 杭州娃哈哈科技有限公司 Application of lactobacillus plantarum in preparation of composition for relieving chronic inflammation of organism
WO2022131192A1 (en) * 2020-12-16 2022-06-23 株式会社明治 Composition for improving inflammation of brain tissue
TWI776433B (en) * 2021-03-22 2022-09-01 生合生物科技股份有限公司 Lactobacillus delbrueckii subsp. lactis ldl557 isolate and uses of the same
CN118302515A (en) 2021-07-12 2024-07-05 国立大学法人东京医科齿科大学 Autophagy-activating composition
CN113637609A (en) * 2021-08-17 2021-11-12 大连工业大学 Lactobacillus plantarum for reducing milk protein antigenicity
CN114395514B (en) * 2022-02-28 2023-09-01 鲁东大学 Lactobacillus acidophilus, microbial inoculum and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL347029A1 (en) * 1998-10-01 2002-03-11 Probi Ab Reduction of oxidative stress factors
KR100686558B1 (en) * 2004-09-02 2007-02-23 씨제이 주식회사 Lactobacillus plantarum with body-fat reducing activity and the foods containing them
JP2008214253A (en) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd Visceral fat reduction agent

Also Published As

Publication number Publication date
WO2012014971A1 (en) 2012-02-02
JPWO2012014971A1 (en) 2013-09-12
JP5076029B2 (en) 2012-11-21
CN103314099B (en) 2014-12-03
CN103314099A (en) 2013-09-18

Similar Documents

Publication Publication Date Title
HK1184187A1 (en) Lactic bacterium having an effect of ameliorating metabolic syndrome
HK1200116A1 (en) Bacterium for use as a probiotic for nutritional and medical applications
PL2646425T3 (en) Indanyloxydihydrobenzofuranylacetic acids useful for the treatment of metabolic syndrome
HK1191671A1 (en) Drying lactic acid bacteria and new compositions
EP2847152A4 (en) Compositions and methods for the treatment of metabolic syndrome
ZA201308607B (en) Nutritional compositions having alpha-hica and alpha-ketoglutarate
HK1199694A1 (en) Probiotic compositions and methods
EP2697978A4 (en) Estimating demographic compositions of television audiences
EP2663635A4 (en) Microbial compositions and methods
PL2685994T3 (en) Probiotic bacteria having antioxidant activity and use thereof
HK1190936A1 (en) Methods and compositions for treating metabolic syndrome
AP3268A (en) Co-crystals and salts of CCR3-inhibitors
EP2572730A4 (en) Method for prevention or treatment of metabolic syndrome
PL2521769T3 (en) Lactobacilli with anti-oxidant action
HUE038336T2 (en) Modified gram positive bacteria and uses thereof
AU337697S (en) Part of furniture drawers
PL2609380T3 (en) Refrigerating furniture
ZA201302854B (en) Substituted benzamides and their uses
ZA201209666B (en) Salts and polymorhs of dexrabeprazole
EP2682116A4 (en) Metabolic syndrome ameliorating agent
HUE038830T2 (en) Modified gram positive bacteria and uses thereof
EP2600716A4 (en) Methods and compositions for treatment of metabolic disorders
EP2598631A4 (en) Recombinant bacterium and uses thereof
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
PL2630426T3 (en) Refrigerator and stopping arrangement of refrigerator shelf